Valsartan Cancer Lawsuits

Fighting for Patients Exposed to Contaminated Blood Pressure Medications

Valsartan, a widely prescribed medication for high blood pressure and heart failure, was once trusted by millions of patients. But in 2018, the U.S. Food and Drug Administration (FDA) announced that certain batches of Valsartan and related drugs were contaminated with cancer-causing chemicals known as NDMA, NDEA, and NMBA.

If you or a loved one developed cancer after taking contaminated Valsartan, you may be entitled to compensation. Our firm represents patients across the country who were unknowingly exposed to these toxic impurities and are now seeking justice from the pharmaceutical companies responsible.

What Went Wrong with Valsartan

Valsartan is an angiotensin II receptor blocker (ARB) used to manage hypertension and heart conditions. However, several manufacturers sourced active pharmaceutical ingredients (APIs) from overseas facilities—particularly in China and India—where unsafe manufacturing practices led to chemical contamination during production.

These carcinogenic impurities, primarily N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), can form when certain solvents and reagents interact under poor quality control conditions.

The contamination went unnoticed for years, potentially exposing thousands of patients to dangerous levels of these substances every day.

FDA Recalls and Safety Findings

Beginning in July 2018, the FDA issued a sweeping recall of Valsartan products distributed under multiple brand and generic names. Affected manufacturers included:

• Zhejiang Huahai Pharmaceutical Co. Ltd. (China)

• Hetero Labs Ltd. (India)

• Macleods Pharmaceuticals

• Torrent Pharmaceuticals

• Teva Pharmaceuticals

Subsequent testing revealed NDMA contamination levels far above the FDA’s acceptable daily intake limit—enough to increase the risk of developing cancer over long-term use.

Cancers Linked to Contaminated Valsartan

Prolonged exposure to NDMA and related compounds has been associated with an increased risk of:

• Liver cancer

• Stomach cancer

• Colorectal cancer

• Kidney cancer

• Pancreatic cancer

• Bladder cancer

If you were diagnosed with any of these conditions after taking Valsartan, it’s critical to have your prescription history reviewed as soon as possible.

Legal Claims Against Manufacturers

Valsartan lawsuits allege that drug manufacturers and distributors:

• Failed to ensure safe manufacturing practices

• Neglected to test products for known chemical impurities

• Did not warn consumers or healthcare providers about potential contamination risks

• Sold adulterated drugs in violation of federal safety laws

Plaintiffs are seeking damages for medical costs, pain and suffering, lost wages, and other losses caused by these preventable exposures.